Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical ...
Leadership
Bassil I. Dahiyat Ph.D.Founder
Co-Founder, CEO, President & Director
Bart Jan Cornelissen
Senior VP & CFO
John R. Desjarlais Ph.D.
Executive VP of Research & Chief Scientific Officer
Celia E. Eckert J.D.
Senior VP, General Counsel & Corporate Secretary
Charles Liles
Associate Director and Head of Corporate Communications & Investor Relations
Jennifer Sandoz
Senior VIce President of Human Resources
Kirk Rosemark RAC
Senior Vice President of Regulatory Affairs & Quality Assurance
Eric P. Kowack
Senior Vice President of Program Leadership & Alliance Management
Dane Vincent Leone C.F.A.
Executive VP & Chief Strategy Officer
Mark Osterman M.D.
Senior Vice President of Clinical Development (Autoimmune)
